EP3406251
Pýrúvat-kínasa-virkjar til notkunar í meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.5.2012EP published:
29.11.2023EP application number:
18166225.5
EP translation filed:
29.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
2.5.2032Expiry date:
2.5.2026Next due date:
31.5.2026
Title in English:
PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPYLanguage of the patent:
English
Timeline
Today
3.5.2012EP application
29.11.2023EP Publication
29.1.2024Translation submitted
15.2.2024Registration published
2.5.2026Expires
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
SU, Shin-San MichaelAddress:
Boston, MA 02116, US
Name:
DANG, LennyAddress:
Boston, MA 02118, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161482171 PDate:
3.5.2011Country:
US
Classification
Categories:
A61K 31/4965, A61K 31/497, A61P 7/06
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 18.4.2024
Expires: 2.5.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.5.2025
Expires: 2.5.2026
Payer: Árnason Faktor ehf.